Along this line, it was shown that co-expressed in the same tumor cell Ephrin A3 binding in cis (ligand and receptor on the same cell) can block EphA2 and EphA3 in trans (ligand and receptor on different cells) ligand binding [29]. The gene discussed is EPHA2; the disease is neoplasm.